Octant Bio (Series B)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$225,000,000
Company Info
Founders
Sri Kosuri
Market
Healthcare & Wellness
Coinvestors
Fifty Years,Bristol-Myers Squibb,Catalio Capital Management,Andreessen Horowitz
Company Description

Developer of synthetic technology used to improve health and treat disease Octant Bio is a developer of synthetic technology used to improve health and treat disease.